Gene · 6607
NIH grants1,484
NIH grants whose papers are about the gene, through NIH's grant-paper links.
661 to 680 of 1,484
Download this page as JSON| Grant | Title | SMN2 papers | Newest fiscal year |
|---|---|---|---|
| U24HG008956 | NHGRI Genome Sequencing Program Coordinating Center | 1 | 2020 |
| U54CA193313 | Topology of Cancer Evolution and Heterogeneity | 1 | 2020 |
| UG3NS111688 | Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain | 1 | 2020 |
| UG3NS116921 | RNA Targeted Drug Discovery and Development for Parkinson Disease | 1 | 2020 |
| R01GM097455 | Sequence-based Design of Small Molecules Targeting RNA | 10 | 2019 |
| DP1NS096898 | Using a disease-affected cell to synthesize its own drug | 9 | 2019 |
| P30GM114736 | Center for Pediatric Research (CPR) | 8 | 2019 |
| R01GM118636 | In vivo models of small RNP biogenesis and Spinal Muscular Atrophy | 6 | 2019 |
| R01GM062287 | Mechanisms of Enhancer Dependent SpliceSite Activation | 5 | 2019 |
| R21NS108015 | Neural and non-neural contributions to phenotype in human SMA type 1 | 5 | 2019 |
| U54HD087011 | WASHINGTON UNIVERSITY INTELLECTUAL AND DEVELOPMENTAL DISABILITIES RESEARCH CENTER | 4 | 2019 |
| K01MH103594 | IMAGING BRAIN FUNCTION IN CHILDREN WITH AUTISM SPECTRUM DISORDERS WITH DIFFUSE OPTICAL TOMOGRAPHY | 3 | 2019 |
| R01NS091749 | RNA Processing Defects in SMA and Their Contribution to the Disease Phenotype | 3 | 2019 |
| R33NS096032 | Developing Novel RNA-Based Therapeutics for Parkinson's Disease | 3 | 2019 |
| U54HD079123 | Intellectual and Developmental Disabilities Research Centers 2013 | 3 | 2019 |
| F30NS098551 | Excitatory spinal micro-circuit mechanisms involved in locomotor activity | 2 | 2019 |
| R01AG033040 | MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults | 2 | 2019 |
| R01AG049607 | Preclinical AD: Correlates of Amyloid, Tau PET and fcMRI in Framingham Gen 3 Young Adults | 2 | 2019 |
| R01NS020480 | Formation and maintenance of neuromuscular synaptic connections | 2 | 2019 |
| R01NS063964 | TDP-43, RNA Metabolism, and ALS/FTD Pathology | 2 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/grants?page=34